Extendicare Inc (EXE.TO) has seen a notable decline this week amid mixed news from the company and the broader healthcare market.
This week, Extendicare Inc's stock has experienced downward pressure, closing at C$29.84, down 2.65% on the day and 6.09% for the week. The company's recent performance reflects broader trends in the healthcare sector, as investors digest recent announcements and ongoing market conditions.
Investor takeaway: With a year-to-date gain of 41.22%, Extendicare remains a significant player in the healthcare sector, but recent price declines may prompt investors to reassess their positions amid mixed news and technical indicators.
Advertisement
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$2.91B
P/E
23.5x
Div. yield
1.66%
Div. / share
$0.51
52W high
$39.04
52W low
$12.55
1W change
-6.09%
Beta
1.16
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 33.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$39.83
+33.8% Upside
Current Price
C$29.77
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
31.7%
Annualized
90-Day Vol
35.9%
Annualized
Trend (90d)
-45.0%
Annualized drift
90d Mean
C$25.35
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$28.22 | C$25.29 โ C$31.48 |
| 60 trading days | C$26.74 | C$22.91 โ C$31.22 |
| 90 trading days | C$25.35 | C$20.97 โ C$30.63 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$29.84 closing price, down 2.65% today.
The stock has seen a significant decline of 16.09% over the past month, despite a strong year-to-date performance.
Bull case
The company's strong year-to-date performance and recent announcements of earnings growth suggest it has a resilient business model. If the healthcare market stabilizes, Extendicare could continue to thrive.
Bear case
However, the recent stock price drop and its decline against moving averages indicate potential challenges ahead. This may lead to cautious sentiment among investors.
Current Price Action
Advertisement
As of the latest close, Extendicare Inc (EXE.TO) is trading at C$29.84, marking a decrease of 2.65% for the day. Over the past week, the stock has declined by 6.09%, and it has seen a more pronounced drop of 16.09% in the last month. Despite these recent challenges, the stock still boasts a year-to-date increase of 41.22%, reflecting its strong performance earlier in the year.
Company News and Developments
Currently, there are no major news headlines directly affecting Extendicare Inc this week. However, the company has been in the news recently for its strong second-quarter results announced in August 2026, which highlighted a 71.7% increase in Adjusted EBITDA, driven by strategic acquisitions and organic growth. Additionally, proposed changes to the Board of Directors and other corporate governance updates have been a focus, though these developments may not have an immediate impact on stock performance.
Technical Picture
From a technical standpoint, Extendicare is currently trading below its 50-day moving average of C$34.85, indicating a bearish trend, as it is down 14.4% compared to this average. The stock is above its 200-day moving average of C$28.29 by 5.5%. The 52-week range has been C$12.55 to C$39.04, with the current price sitting at approximately 65% of this range. The stock's beta of 1.16 suggests it is slightly more volatile than the broader market, while the recent trading volume of 688,962 shares is below the 20-day average of 600,208 shares, reflecting reduced investor activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
